These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8890105)

  • 21. [Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers].
    Matos-Benavides E; García-Gomero D; Inocente-Malpartida R; Córdova-Calderón W; Aldave-Becerra J
    Rev Peru Med Exp Salud Publica; 2019; 36(4):664-669. PubMed ID: 31967259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin heavy chain gene rearrangements in X-linked agammaglobulinemia.
    Mensink EJ; Schuurman RK; Schot JD; Thompson A; Alt FW
    Eur J Immunol; 1986 Aug; 16(8):963-7. PubMed ID: 3091379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closing in on type 1 diabetes.
    McDevitt H
    N Engl J Med; 2001 Oct; 345(14):1060-1. PubMed ID: 11586961
    [No Abstract]   [Full Text] [Related]  

  • 24. Incomplete block of B cell development and immunoglobulin production in mice carrying the muMT mutation on the BALB/c background.
    Hasan M; Polic B; Bralic M; Jonjic S; Rajewsky K
    Eur J Immunol; 2002 Dec; 32(12):3463-71. PubMed ID: 12442328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the B-lymphocyte population in agammaglobulinemia.
    Geha RS; Gatien JG; Merler E; Rosen FS
    Birth Defects Orig Artic Ser; 1975; 11(1):36-9. PubMed ID: 1096986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding of IgM aggregates to neoplastic B lymphocytes. II. Fc dependence and implications for a model of B lymphocyte differentiation.
    Rudders RA; Andersen J; Fried R
    J Immunol; 1980 May; 124(5):2347-51. PubMed ID: 6767785
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and molecular analysis of patients with defects in micro heavy chain gene.
    Lopez Granados E; Porpiglia AS; Hogan MB; Matamoros N; Krasovec S; Pignata C; Smith CI; Hammarstrom L; Bjorkander J; Belohradsky BH; Casariego GF; Garcia Rodriguez MC; Conley ME
    J Clin Invest; 2002 Oct; 110(7):1029-35. PubMed ID: 12370281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal recessive agammaglobulinemic patient with a novel large deletion in IGHM presenting with mild clinical phenotype.
    Nain E; Ulgen O; Kiykim A; Aydiner EK; Ozen A; Baris S
    Clin Immunol; 2020 Jan; 210():108295. PubMed ID: 31683053
    [No Abstract]   [Full Text] [Related]  

  • 29. Autosomal recessive agammaglobulinemia due to defect in μ heavy chain caused by a novel mutation in the IGHM gene.
    Silva P; Justicia A; Regueiro A; Fariña S; Couselo JM; Loidi L
    Genes Immun; 2017 Sep; 18(3):197-199. PubMed ID: 28769069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and cellular aspects of X-linked agammaglobulinemia.
    Sideras P; Smith CI
    Adv Immunol; 1995; 59():135-223. PubMed ID: 7484460
    [No Abstract]   [Full Text] [Related]  

  • 31. Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1.
    Kury P; Staniek J; Wegehaupt O; Janowska I; Eckenweiler M; Korinthenberg R; Japaridze N; Pendziwiat M; Helbig I; Verhoeyen E; Jung J; Garcia de Oteyza AC; Proietti M; Phirtskhalaishvili T; Rtskhiladze I; Nielsen PJ; Ehl S; Speckmann C; Rizzi M
    J Allergy Clin Immunol; 2021 May; 147(5):1977-1980. PubMed ID: 33571536
    [No Abstract]   [Full Text] [Related]  

  • 32. Neutropenia associated with X-linked agammaglobulinaemia.
    Kozlowski C; Evans DI
    J Clin Pathol; 1991 May; 44(5):388-90. PubMed ID: 2045497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of xid mutation in X-linked agammaglobulinaemia.
    Vorechovsky I; Zhou JN; Hammarström L; Smith CI; Thomas JD; Paul WE; Notarangelo LD; Bernatowska-Matuszkiewicz E
    Lancet; 1993 Aug; 342(8870):552. PubMed ID: 8102684
    [No Abstract]   [Full Text] [Related]  

  • 34. Are most "null" cells B cells?
    Dhaliwal HS; Haeney MR; Ling NR
    Lancet; 1980 May; 1(8177):1092. PubMed ID: 6103430
    [No Abstract]   [Full Text] [Related]  

  • 35. IgE-bearing lymphocytes and atopy in a patient with X-linked infantile agammaglobulinaemia.
    Gajl-Peczalska KJ; Ballow M; Hansen JA; Good RA
    Lancet; 1973 Jun; 1(7814):1254. PubMed ID: 4122604
    [No Abstract]   [Full Text] [Related]  

  • 36. Lessons in gene hunting: a RAG1 mutation presenting with agammaglobulinemia and absence of B cells.
    Hedayat M; Massaad MJ; Lee YN; Conley ME; Orange JS; Ohsumi TK; Al-Herz W; Notarangelo LD; Geha RS; Chou J
    J Allergy Clin Immunol; 2014 Oct; 134(4):983-5.e1. PubMed ID: 24985406
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug reaction to ceftriaxone in a child with X-linked agammaglobulinemia.
    Kudva-Patel V; White E; Karnani R; Collins MH; Assa'ad AH
    J Allergy Clin Immunol; 2002 May; 109(5):888-9. PubMed ID: 11994716
    [No Abstract]   [Full Text] [Related]  

  • 38. Isolation of the defective gene in X linked agammaglobulinaemia.
    Vetrie D
    J Med Genet; 1993 Jun; 30(6):452-3. PubMed ID: 8326486
    [No Abstract]   [Full Text] [Related]  

  • 39. Two distinct stages of B-cell defects in X-linked agammaglobulinaemia.
    Dobozy A; Husz S; Hunyadi J
    J R Soc Med; 1986 Jan; 79(1):60. PubMed ID: 3484787
    [No Abstract]   [Full Text] [Related]  

  • 40. TCF3 Dominant Negative Variant Causes an Early Block in B-Lymphopoiesis and Agammaglobulinemia.
    Al Sheikh E; Arkwright PD; Herwadkar A; Hussell T; Briggs TA
    J Clin Immunol; 2021 Aug; 41(6):1391-1394. PubMed ID: 33905048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.